Fraxiparine

Fraxiparine is a medication containing Nadroparin Calcium, used for anticoagulation and blood thinning. It is commonly administered via haemodialysis, intravenous, or subconjunctival routes. This product is manufactured by Viatris Healthcare Limited in the EU.

Fraxiparine is primarily used for anticoagulation, helping to prevent blood clots in various medical conditions. It is often utilized in procedures like haemodialysis and other treatments requiring blood thinning. The medication works by inhibiting certain clotting factors, making it useful for conditions where clotting is a risk.

Common effects of Fraxiparine may include bruising, bleeding, and irritation at the injection site. Some users might experience allergic reactions, though these are less frequent. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Fraxiparine should be handled with care, especially by individuals with a history of bleeding disorders or those taking other blood-thinning medications. It is crucial to follow the prescribed administration route, whether haemodialysis, intravenous, or subconjunctival, to ensure safety and effectiveness. Always store the medication as directed to maintain its potency.

Fraxiparine may interact with other medications that affect blood clotting, such as aspirin or warfarin. Alcohol consumption should be moderated, as it can increase the risk of bleeding. It is also important to inform healthcare providers about all current medications to avoid potential interactions.